๐๐ฆ๐ก๐ ๐๐ผ๐ป๐ด๐ฟ๐ฒ๐๐ | ๐๐ฎ๐น๐ถ, ๐๐ป๐ฑ๐ผ๐ป๐ฒ๐๐ถ๐ฎ | ๐ด – ๐ญ๐ฌ ๐๐๐ด๐๐๐ ๐ฎ๐ฌ๐ฎ๐ฑ

๐๐ฆ๐ก๐ ๐๐ผ๐ป๐ด๐ฟ๐ฒ๐๐ | ๐๐ฎ๐น๐ถ, ๐๐ป๐ฑ๐ผ๐ป๐ฒ๐๐ถ๐ฎ | ๐ด – ๐ญ๐ฌ ๐๐๐ด๐๐๐ ๐ฎ๐ฌ๐ฎ๐ฑ
Together with PT. Ferron Par Pharmaceuticals, Moleac was delighted to participate in the 16แตสฐ Biennial Convention of the ASEAN Neurological Association (ASNA) 2025, held last week in Bali, Indonesia. This prestigious congress brought together neurologists and allied healthcare professionals, offering a rich program of presidential lectures, plenary symposiums, and parallel scientific sessions.
Dr. N. V. Ramani, Chair of the Asian Stroke Advisory Panel (ASAP), presented a poster on โMeta-Analysis of Effect of MLC601/MLC901 on Motor Recovery after Strokeโ. The presentation summarized multiple clinical trials on NeuroAiD, reinforcing its role in post-stroke motor recovery and fostering valuable discussions with stroke care experts.
Moleac was proud to connect with the neurology community, exchange insights, and showcase our commitment to advancing neurological care in Southeast Asia and beyond.
To learn more about our work and commitment to neurological health, please visit www.moleac.com.